LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 7.66 | 770.25 | 1118 | 1090 | 1.0257 | 1.1039 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 7.66 | 770.25 | 1014 | 1090 | 0.9303 | 0.7313 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 10.06 | 770.25 | 1209 | 1218 | 0.9922 | 0.9765 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 10.06 | 770.25 | 1076 | 1218 | 0.8831 | 0.6573 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 12.28 | 770.25 | 1354 | 1358 | 0.9970 | 0.9926 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 12.28 | 770.25 | 1215 | 1358 | 0.8946 | 0.7455 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 14.50 | 770.25 | 1509 | 1497 | 1.0078 | 1.0164 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 14.50 | 770.25 | 1354 | 1497 | 0.9043 | 0.8009 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 16.73 | 770.25 | 1601 | 1664 | 0.9619 | 0.9312 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 16.73 | 770.25 | 1463 | 1664 | 0.8789 | 0.7808 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 18.95 | 770.25 | 1612 | 1832 | 0.8797 | 0.8051 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 18.95 | 770.25 | 1518 | 1832 | 0.8284 | 0.7204 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 21.17 | 770.25 | 1667 | 2008 | 0.8300 | 0.7479 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 21.17 | 770.25 | 1559 | 2008 | 0.7763 | 0.6652 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 23.39 | 770.25 | 1704 | 2244 | 0.7592 | 0.6730 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 23.39 | 770.25 | 1570 | 2244 | 0.6995 | 0.5865 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 25.62 | 770.25 | 1719 | 2514 | 0.6835 | 0.6004 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 25.62 | 770.25 | 1619 | 2514 | 0.6438 | 0.5452 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 27.84 | 770.25 | 1742 | 2833 | 0.6147 | 0.5438 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 27.84 | 770.25 | 1663 | 2833 | 0.5868 | 0.5061 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 30.06 | 770.25 | 1802 | 3106 | 0.5801 | 0.5258 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 30.06 | 770.25 | 1693 | 3106 | 0.5451 | 0.4792 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 32.28 | 770.25 | 1853 | 3392 | 0.5461 | 0.5074 | MN20160304_L02 | C11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 32.28 | 770.25 | 1757 | 3392 | 0.5179 | 0.4704 | MN20160304_L02 | F12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0056667 | 34.50 | 770.25 | 1909 | 3712 | 0.5143 | 0.4919 | MN20160304_L02 | C11 |